Value of Size and Malignant Features of Lateral Lymph Nodes in Risk Stratification at Lateral Local Recurrence of Rectal Cancer: A National Cohort Study

Author:

van Geffen Eline G.M.12,Sluckin Tania C.12,Hazen Sanne-Marije J.A.12,Horsthuis Karin23,Beets-Tan Regina G.H.4567,van Dieren Susan1,Marijnen Corrie A.M.89,Tanis Pieter J.21011,Kusters Miranda12

Affiliation:

1. Department of Surgery, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

2. Cancer Center Amsterdam, Treatment and Quality of Life, Imaging and Biomarkers, Amsterdam, the Netherlands

3. Department of Radiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

4. Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

5. GROW School for Oncology and Developmental Biology, University of Maastricht, Maastricht, the Netherlands

6. Department of Radiology, Odense University Hospital, Odense, Denmark

7. Department of Clinical Research University of Southern Denmark, Odense, Denmark

8. Department of Radiation Oncology, Leiden UMC, Leiden, the Netherlands

9. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

10. Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

11. Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus Medical Center, Rotterdam, the Netherlands

Abstract

Background: Patients with rectal cancer who have enlarged lateral lymph nodes (LLNs) have an increased risk of lateral local recurrence (LLR). However, little is known about prognostic implications of malignant features (internal heterogeneity, irregular margins, loss of fatty hilum, and round shape) on MRI and number of enlarged LLNs, in addition to LLN size. Methods: Of the 3,057 patients with rectal cancer included in this national, retrospective, cross-sectional cohort study, 284 with a cT3–4 tumor located ≤8 cm from the anorectal junction who received neoadjuvant treatment and who had visible LLNs on MRI were selected. Imaging was reassessed by trained radiologists. LLNs were categorized based on size. Influence of malignant features and the number of LLNs on LLR was investigated. Results: Of 284 patients with at least 1 visible LLN, 122 (43%) had an enlarged node (≥7.0 mm) and 157 (55%) had malignant features. Of the 122 patients with enlarged nodes, 25 had multiple (≥2). In patients with a single enlarged node (n=97), a single malignant feature was associated with a 4-year LLR rate of 0% and multiple malignant features was associated with a rate of 17% (P=.060). In the group with multiple malignant features, their disappearance on restaging was associated with an LLR rate of 13% compared with an LLR rate of 20% for persistent malignant features (P=.532). The presence of intermediate-size LLNs (5.0–6.9 mm) with at least 1 malignant feature was associated with a 4-year LLR rate of 8%; the 4-year LLR rate was 13% when the malignant features persisted on restaging MRI (P=.409). Patients with multiple enlarged LLNs had a 4-year LLR rate of 28% compared with 11% for those with a single enlarged LLN (P=.059). Conclusions: The presence of multiple enlarged LLNs (≥7.0 mm), as well as multiple malignant features in an enlarged node contribute to the risk of developing an LLR. These radiologic features can be used for clinical decision-making regarding the potential benefit of LLN dissection.

Publisher

Harborside Press, LLC

Reference21 articles.

1. Experts reviews of the Multidisciplinary Consensus Conference Colon and Rectal Cancer 2012: science, opinions and experiences from the experts of surgery;van de Velde CJ,2014

2. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions;Iversen H,2018

3. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases;Steup WH,2002

4. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging;Akiyoshi T,2014

5. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer;Matsuda T,2018

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3